Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

(123)I-FP-CIT SPECT imaging in early diagnosis of dementia in patients with and without a vascular component.

Garriga M, Milà M, Mir M, Al-Baradie R, Huertas S, Castejon C, Casas L, Badenes D, Giménez N, Font MA, Gonzalez JM, Ysamat M, Aguilar M, Slevin M, Krupinski J.

Front Syst Neurosci. 2015 Jul 1;9:99. doi: 10.3389/fnsys.2015.00099. eCollection 2015.

2.

[Study of the pre and post-synaptic dopaminergic system by DaTSCAN/IBZM SPECT in the differential diagnosis of parkinsonism in 75 patients].

Vaamonde J, Ibáñez R, García AM, Poblete V.

Neurologia. 2004 Jul-Aug;19(6):292-300. Spanish.

PMID:
15199417
3.

Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease - An Unexpected Finding?

Bittner V, Ullrich G, Thormann M, Müller NG, Friederichs C, Amthauer H, Heinze HJ, Bittner DM.

Dement Geriatr Cogn Dis Extra. 2011 Jan;1(1):283-91. doi: 10.1159/000330470. Epub 2011 Sep 21.

4.

Impact of 123I-FP-CIT (DaTSCAN) SPECT on the diagnosis and management of patients with dementia with Lewy bodies: a retrospective study.

Kemp PM, Clyde K, Holmes C.

Nucl Med Commun. 2011 Apr;32(4):298-302. doi: 10.1097/MNM.0b013e328343d4ec.

PMID:
21278615
5.

Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease.

Brajkovic LD, Svetel MV, Kostic VS, Sobic-Saranovic DP, Pavlovic SV, Artiko VM, Obradovic VB.

Hell J Nucl Med. 2012 May-Aug;15(2):134-8.

PMID:
22833860
6.

123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias.

Brigo F, Turri G, Tinazzi M.

J Neurol Sci. 2015 Dec 15;359(1-2):161-71. doi: 10.1016/j.jns.2015.11.004. Epub 2015 Nov 3. Review.

PMID:
26671107
7.

Is mild cognitive impairment prodromal for vascular dementia like Alzheimer's disease?

Meyer JS, Xu G, Thornby J, Chowdhury MH, Quach M.

Stroke. 2002 Aug;33(8):1981-5.

PMID:
12154249
8.

123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results.

Jauković L, Ilić TV, Dopudja M, Ajdinović B.

Vojnosanit Pregl. 2012 Feb;69(2):157-62.

PMID:
22500370
9.

[123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes.

Hauser RA, Grosset DG.

J Neuroimaging. 2012 Jul;22(3):225-30. doi: 10.1111/j.1552-6569.2011.00583.x. Epub 2011 Mar 16. Review.

PMID:
21410815
10.

[Effectiveness of 123I-ioflupane (DaTSCAN) in the diagnosis of Parkinsonian syndromes. A systematic review].

Puñal Riobóo J, Varela Lema L, Serena Puig A, Ruano-Ravina A.

Rev Esp Med Nucl. 2007 Nov-Dec;26(6):375-84. Review. Spanish.

11.

The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia.

Dukic L, Simundic AM, Martinic-Popovic I, Kackov S, Diamandis A, Begcevic I, Diamandis EP.

Clin Biochem. 2016 Feb;49(3):213-8. doi: 10.1016/j.clinbiochem.2015.10.014. Epub 2015 Oct 26.

PMID:
26515085
12.

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.

Benamer TS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, Speelman JD, Horstink MH, Sips HJ, Dierckx RA, Versijpt J, Decoo D, Van Der Linden C, Hadley DM, Doder M, Lees AJ, Costa DC, Gacinovic S, Oertel WH, Pogarell O, Hoeffken H, Joseph K, Tatsch K, Schwarz J, Ries V.

Mov Disord. 2000 May;15(3):503-10.

PMID:
10830416
13.

[1231-FP-CIT (DaTSCAN) scintigraphy in the differential diagnosis of movement disorders].

Dethy S, Hambye AS.

Rev Med Brux. 2008 Sep;29(4):238-47. Review. French.

PMID:
18949971
14.

Prevalence and severity of symptoms suggestive of gastroparesis in prodromal dementia with Lewy bodies.

Durcan R, Donaghy PC, Barnett NA, Olsen K, Yarnall AJ, Taylor JP, McKeith I, O'Brien JT, Thomas AJ.

Int J Geriatr Psychiatry. 2019 Mar 22. doi: 10.1002/gps.5100. [Epub ahead of print]

PMID:
30901488
15.

Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.

Yoon JH, Kim M, Moon SY, Yong SW, Hong JM.

J Neurol Sci. 2015 Aug 15;355(1-2):174-9. doi: 10.1016/j.jns.2015.06.013. Epub 2015 Jun 10.

PMID:
26076880
16.

SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson's disease?

Gerasimou G, Costa DC, Papanastasiou E, Bostanjiopoulou S, Arnaoutoglou M, Moralidis E, Aggelopoulou T, Gotzamani-Psarrakou A.

Ann Nucl Med. 2012 May;26(4):337-44. doi: 10.1007/s12149-012-0577-4. Epub 2012 Mar 3.

PMID:
22382608
17.

The diagnosis of "mixed" dementia in the Consortium for the Investigation of Vascular Impairment of Cognition (CIVIC).

Rockwood K, Macknight C, Wentzel C, Black S, Bouchard R, Gauthier S, Feldman H, Hogan D, Kertesz A, Montgomery P.

Ann N Y Acad Sci. 2000 Apr;903:522-8.

PMID:
10818547
18.
19.

Study protocol on Alzheimer's disease and related disorders: focus on clinical and imaging predictive markers in co-existing lesions.

Boublay N, Fédérico D, Pesce A, Verny M, Blanc F, Paccalin M, Desmidt T, Grosmaître P, Moreaud O, Relland S, Bravant E, Bouet R, Krolak-Salmon P.

BMC Geriatr. 2018 Nov 14;18(1):280. doi: 10.1186/s12877-018-0949-2.

20.

123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease.

Navarro-Otano J, Gaig C, Muxi A, Lomeña F, Compta Y, Buongiorno MT, Martí MJ, Tolosa E, Valldeoriola F.

Parkinsonism Relat Disord. 2014 Feb;20(2):192-7. doi: 10.1016/j.parkreldis.2013.10.025. Epub 2013 Nov 5.

PMID:
24252299

Supplemental Content

Support Center